Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Insight into Infectious Diseases Could Lead to Preventive Vaccines for Some Rheumatic Illnesses

Thomas R. Collins  |  Issue: August 2016  |  August 11, 2016

Research is showing the potential role of infectious agents in rheumatic diseases.

Research is showing the potential role of infectious agents in rheumatic diseases.
science photo/shutterstock.com

CHICAGO—Medicine is in the middle of an infectious-disease “revolution” that seems almost destined to lead to prevention through immunization of many diseases, including rheumatic illnesses, that never were previously thought to involve transmissible agents, an infectious disease specialist said in a session at the ACR’s 2016 State-of-the-Art Clinical Symposium.

An array of unlikely and fascinating connections between infections and diseases have been discovered over the past several decades—links of viruses and cancer, the discovery that the key to peptic ulcer disease isn’t acid, but the bacterium Helicobacter pylori, to name a couple of examples. And the rate of research in this area is mushrooming, said Bennett Lorber, MD, MACP, professor of medicine at the Lewis Katz School of Medicine at Temple University.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A Paradigm Shift

Dr. Lorber

Dr. Lorber

“There’s been a giant paradigm shift in our understanding of the relationship between microorganisms and human beings,” said Dr. Lorber, who himself is barely able to contain his excitement at some of the amazing findings. “We’re in the middle of a scientific revolution.”

One of the more incredible discoveries was the Nobel Prize-winning discovery that what appeared to be a neurodegenerative disease, Kuru, in people who live in the highlands of Papua New Guinea, was actually a transmissible disease with an incubation period of years or decades. The highlanders honor their dead by eating them, and the disease was being transmitted this way: Those who prepared or ate the brains of the dead had the highest rates of attack.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Spongiform encephalopathies, like Kuru, are caused by tiny bits of protein with no nucleic acid, or prions, a discovery so contrary to conventional science it was “heretical,” Dr. Lorber said. The discovery won Stanley Prusiner, MD, the Nobel Prize in 1997.

In PANDAS—pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections—children who get strep throat within two months have a dramatic onset of obsessive compulsive disorder, and those with OCD suddenly worsen. Penicillin prophylaxis helps with this, Dr. Lorber said.

Infectious Agents

The potential role of infectious agents can be seen in rheumatic diseases, as well.

People with rheumatoid arthritis have periodontal diseases more often, and worse cases of it, than controls. The major cause of periodontitis is the bacterium Porphyromonas gingivalis, which produces arginine proteinases that it needs in order to live in gingival crevices. One of these proteinases, peptidylarginine deiminase, coverts arginine to citrulline. Of course, people with RA have antibodies to cyclic citrullinated peptides.1

“Porphyromonas gingivalis is the only bacterium known to do that,” Dr. Lorber said. “The idea here is that this organism, in genetically susceptible individuals, makes citrullinated antigens that then serve as systemic immunogens, resulting in rheumatoid arthritis.”

The Microbiome

Research in heart disease has found that, after inoculating human cells with Chlamydophila pneumonia, the bacterium up-regulates genes with important pro-inflammatory functions, including those associated with atherosclerosis.

Another shift is occurring, too, Dr. Lorber said. Ever since anthrax was proved to be caused by bacteria, more than a hundred years ago, there was a belief that one disease was caused by one organism. But that might not always be the case, new evidence is showing.

“It may not be one organism,” Dr. Lorber said. “It may be populations of organisms or relative proportions of populations. So maybe it’s not infection in the traditional sense. Maybe it’s an imbalance of the microbiome,” or “dysbiosis.”

For example, using new tools, such as 16S sequencing—a way to assess the taxonomy in difficult-to-study microbiomes—in people with RA and in controls, researchers have found that the presence of Prevotella copri bacteria, with an associated reduction in the normal Bacteroidetes population, is correlated strongly with new onset of RA.2

Scientists are also shedding light on the so-called “gut–brain axis,” signaling in which the gut talks to the brain through neural mechanisms, including the vagus nerve, as well as endocrine mechanisms, immune mechanisms and metabolic mechanisms.

Germ-free mice that are deliberately stressed develop higher levels of stress hormone, as well as lower levels than normal mice of a brain protein that modulates synaptic growth and transmission.3

“If you recolonize with normal mice gut flora, you can reverse that and they lower levels of stress hormones,” Dr. Lorber said.

Obese people, researchers have found, have more Bacteroidetes and fewer Firmicutes than controls who are lean.4

“It turns out that obese individuals who complain all the time (that), ‘I ate the same thing you ate—why don’t you get fat?’ may have a good explanation,” Dr. Lorber said. “They may have more efficient energy harvesting from what they eat.”

‘I think it’s very likely that as time goes by we will establish firmer links between transmissible agents & chronic illness. That’s exciting because it opens the opportunity for prevention through immunization.’ —Bennett Lorber, MD, MACP

Future Possiblities

All of these discoveries are cause for great optimism, he said.

“I really think we may soon be treating neuropsychiatric disorders with probiotics,” Dr. Lorber said. “The hard part is being able to figure out which probiotic is going to do the trick. But just imagine this.

“Who would have imagined 30 years ago that we’d be curing ulcers with antibiotics?” Dr. Lorber said. “I think it’s very likely that as time goes by we will establish firmer links between transmissible agents and chronic illness. And that’s exciting because it opens the opportunity for prevention through immunization.”


Thomas R. Collins is a freelance medical writer based in Florida.

Reference

  1. Liao F, Li Z, Wang Y, et al. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis. Med Hypotheses. 2009 Jun;72(6):732–735.
  2. Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. 2013 Nov 5;2:e01202.
  3. Sampson, TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe. 2015 May 13;17(5):565–576.
  4. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006 Dec 21;444(7122):1027–1031.

Page: 1 2 3 | Multi-Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:2016 State-of-the-Art Clinical SymposiumImmunizationinfectious diseasepreventiveResearchRheumatic DiseaseTreatmentvaccine

Related Articles

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

    April 15, 2016

    Recent data suggest that our commensal microbiota are not passive, but reflect and even induce systemic disease. T. L. Furrer/shutterstock.com The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens…

    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    Monkey Business Images/shutterstock.com The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx….

    Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA

    September 17, 2019

    Alpha Tauri 3D Graphics / shutterstock.com Researchers know human leukocyte antigen (HLA) molecules affect susceptibility to disease in general, and immunological disease in particular. In the case of ankylosing spondylitis (AS), the risk is primarily associated with HLA-B27, with smaller effects from other HLA alleles. Current thinking is that AS is caused by the presence…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences